Rothschild Investment LLC’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.1M Buy
211,962
+84,786
+67% +$2.22M 0.19% 109
2026
Q1
$3.57M Buy
127,176
+4,394
+4% +$117K 0.19% 115
2025
Q4
$3.06M Sell
122,782
-8,346
-6% -$210K 0.17% 116
2025
Q3
$3.34M Buy
131,128
+8,112
+7% +$200K 0.19% 113
2025
Q2
$2.98M Sell
123,016
-5,400
-4% -$126K 0.19% 117
2025
Q1
$3.25M Sell
128,416
-13,792
-10% -$361K 0.22% 104
2024
Q4
$3.77M Sell
142,208
-3,602
-2% -$97.7K 0.25% 89
2024
Q3
$4.22M Sell
145,810
-1,044
-0.7% -$30.5K 0.28% 84
2024
Q2
$4.11M Sell
146,854
-1,336
-0.9% -$36.8K 0.29% 78
2024
Q1
$4.11M Sell
148,190
-4,715
-3% -$131K 0.3% 80
2023
Q4
$4.4M Sell
152,905
-14,951
-9% -$452K 0.37% 72
2023
Q3
$5.57M Buy
167,856
+17,242
+11% +$610K 0.47% 63
2023
Q2
$5.53M Buy
150,614
+402
+0.3% +$15.6K 0.46% 61
2023
Q1
$6.13M Sell
150,212
-1,698
-1% -$73.3K 0.54% 54
2022
Q4
$7.78M Buy
151,910
+1,470
+1% +$70.5K 0.71% 38
2022
Q3
$6.58M Sell
150,440
-9,157
-6% -$445K 0.65% 43
2022
Q2
$8.37M Sell
159,597
-13,212
-8% -$673K 0.77% 39
2022
Q1
$8.95M Buy
172,809
+4,829
+3% +$251K 0.7% 38
2021
Q4
$9.92M Sell
167,980
-3,380
-2% -$167K 0.77% 34
2021
Q3
$7.37M Sell
171,360
-23,107
-12% -$1.02M 0.62% 51
2021
Q2
$7.62M Sell
194,467
-2,810
-1% -$109K 0.61% 48
2021
Q1
$7.15M Buy
197,277
+14,576
+8% +$518K 0.62% 43
2020
Q4
$6.72M Sell
182,701
-9,502
-5% -$349K 0.65% 45
2020
Q3
$6.69M Buy
192,203
+32,299
+20% +$1.13M 0.73% 41
2020
Q2
$4.96M Sell
159,904
-49,604
-24% -$1.69M 0.6% 51
2020
Q1
$6.49M Sell
209,508
-36,996
-15% -$1.26M 0.85% 32
2019
Q4
$9.16M Sell
246,504
-12,172
-5% -$434K 0.91% 27
2019
Q3
$8.82M Buy
258,676
+624
+0.2% +$22.7K 1.03% 26
2019
Q2
$10.6M Sell
258,052
-1,108
-0.4% -$44K 1.25% 16
2019
Q1
$10.4M Sell
259,160
-3,727
-1% -$149K 1.22% 17
2018
Q4
$10.9M Buy
262,887
+9,946
+4% +$413K 1.46% 15
2018
Q3
$10.6M Sell
252,941
-1,074
-0.4% -$41.3K 1.25% 18
2018
Q2
$8.74M Sell
254,015
-2,554
-1% -$87.3K 1.1% 21
2018
Q1
$8.64M Sell
256,569
-39,640
-13% -$1.36M 1.11% 24
2017
Q4
$10.2M Sell
296,209
-668
-0.2% -$22.8K 1.11% 24
2017
Q3
$10.1M Sell
296,877
-4,600
-2% -$148K 1.14% 20
2017
Q2
$9.61M Sell
301,477
-9,282
-3% -$293K 1.09% 21
2017
Q1
$10.1M Buy
310,759
+4,360
+1% +$137K 1.17% 18
2016
Q4
$9.44M Buy
306,399
+106
+0% +$3.24K 1.14% 19
2016
Q3
$9.84M Sell
306,293
-3,746
-1% -$125K 1.21% 15
2016
Q2
$10.4M Buy
310,039
+2,273
+0.7% +$72.5K 1.32% 10
2016
Q1
$8.65M Sell
307,766
-6,153
-2% -$176K 1.11% 21
2015
Q4
$9.61M Buy
313,919
+4,921
+2% +$155K 1.22% 11
2015
Q3
$9.21M Buy
308,998
+3,151
+1% +$101K 1.21% 11
2015
Q2
$9.73M Buy
305,847
+2,409
+0.8% +$78.5K 1.13% 15
2015
Q1
$10M Sell
303,438
-3,695
-1% -$117K 1.17% 14
2014
Q4
$9.08M Sell
307,133
-14,208
-4% -$407K 1.08% 16
2014
Q3
$9.02M Buy
321,341
+22,827
+8% +$641K 1.1% 15
2014
Q2
$8.41M Sell
298,514
-198
-0.1% -$5.64K 1.07% 16
2014
Q1
$9.1M Buy
298,712
+817
+0.3% +$24.4K 1.23% 13
2013
Q4
$8.66M Sell
297,895
-4,185
-1% -$122K 1.18% 15
2013
Q3
$8.23M Sell
302,080
-7,826
-3% -$213K 1.21% 17
2013
Q2
$8.24M Buy
+309,906
New +$8.56M 1.34% 14

Other funds holding PFE

Rothschild Investment LLC's PFE Position: Q2 2026 in Review

Rothschild Investment LLC increased its Pfizer (PFE) stake by 67% in Q2 2026, buying an estimated $2.22M and bringing the position to 211,962 shares worth $5.1M. The position accounts for 0.19% of the portfolio, ranked #109.

Rothschild Investment LLC first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $10.9M in Q4 2018. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Rothschild Investment LLC held 211,962 shares of Pfizer worth $5.1M as of Q2 2026.
  • Rothschild Investment LLC bought 84,786 Pfizer shares in Q2 2026, an estimated $2.22M.
  • Pfizer made up 0.19% of Rothschild Investment LLC's portfolio in Q2 2026, its #109 holding.
  • Rothschild Investment LLC first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Rothschild Investment LLC's Pfizer position peaked at $10.9M in Q4 2018.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.